Ibrutinib for Relapsed or Refractory Mantle Cell Lymphoma

NCT04061850 · clinicaltrials.gov ↗
COMPLETED
Status
88
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Samsung Medical Center